Literature DB >> 12239455

Enhanced expression of thymidylate synthase mediates resistance of uterine cervical cancer cells to radiation.

Yasushi Saga1, Mitsuaki Suzuki, Hiroaki Mizukami, Masashi Urabe, Masakuza Fukushima, Keiya Ozawa, Ikuo Sato.   

Abstract

It has been shown that there is an inverse relationship between the level of thymidylate synthase (TS) and therapeutic outcomes in patients with malignancies including cervical cancer. To clarify the mechanism of the poor prognosis of cervical cancer with high TS expression, we introduced TS cDNA to the human uterine cervical cancer cell line SKG-II and evaluated the effect of TS expression on its radiosensitivity. After selection, stable transformants of SKG-II cells expressing high level of TS (SKG-II/TS) and control cells (SKG-II/luciferase) were obtained. The level of TS measured by the FdUMP-TS binding assay was significantly higher (p < 0.05) in SKG-II/TS than in control (2.0 +/- 0.1 and 1.3 +/- 0.1 pmol/mg, respectively). No difference was observed in in vitro cell growth or in vivo tumor growth. On evaluation of in vitro radiosensitivity, the 50% growth inhibitory dose (ID(50)) was 3.1 +/- 0.1 Gy in SKG-II/TS and was significantly higher (p < 0.01) than that in control (2.2 +/- 0.1 Gy). From these results, it is suggested that one of the reasons of poor outcome of cervical cancer to radiation is high TS expression. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12239455     DOI: 10.1159/000063804

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  6 in total

1.  Increased expression of thymidylate synthetase (TS), ubiquitin specific protease 10 (USP10) and survivin is associated with poor survival in glioblastoma multiforme (GBM).

Authors:  Jessica M Grunda; L Burton Nabors; Cheryl A Palmer; David C Chhieng; Adam Steg; Tom Mikkelsen; Robert B Diasio; Kui Zhang; David Allison; William E Grizzle; Wenquan Wang; G Yancey Gillespie; Martin R Johnson
Journal:  J Neurooncol       Date:  2006-06-14       Impact factor: 4.130

2.  Cross-Correlative Single-Cell Analysis Reveals Biological Mechanisms of Nanoparticle Radiosensitization.

Authors:  Tyron Turnbull; Michael Douglass; Nathan H Williamson; Douglas Howard; Richa Bhardwaj; Mark Lawrence; David J Paterson; Eva Bezak; Benjamin Thierry; Ivan M Kempson
Journal:  ACS Nano       Date:  2019-04-29       Impact factor: 15.881

3.  Pemetrexed and cisplatin for the treatment of advanced, persistent, or recurrent carcinoma of the cervix: a limited access phase II trial of the gynecologic oncology group.

Authors:  David Scott Miller; John A Blessing; Lois M Ramondetta; Huyen Q Pham; Krishnansu S Tewari; Lisa M Landrum; Jubilee Brown; Robert S Mannel
Journal:  J Clin Oncol       Date:  2014-07-28       Impact factor: 44.544

4.  Significance of thymidylate synthase expression for resistance to pemetrexed in pulmonary adenocarcinoma.

Authors:  Min Yang; Wei-Fei Fan; Xiao-Lin Pu; Fu-Yin Liu; Li-Juan Meng; Jun Wang
Journal:  Oncol Lett       Date:  2013-11-19       Impact factor: 2.967

5.  Identification of key genes and pathways of diagnosis and prognosis in cervical cancer by bioinformatics analysis.

Authors:  Hua-Ju Yang; Jin-Min Xue; Jie Li; Ling-Hong Wan; Yu-Xi Zhu
Journal:  Mol Genet Genomic Med       Date:  2020-03-17       Impact factor: 2.183

6.  Corosolic acid reduces 5‑FU chemoresistance in human gastric cancer cells by activating AMPK.

Authors:  Jun Beom Park; Jin Sun Lee; Myung Sun Lee; Eun Young Cha; Soyeon Kim; Ji Young Sul
Journal:  Mol Med Rep       Date:  2018-07-03       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.